Franklin Resources
VTGN icon

Franklin Resources’s VistaGen Therapeutics VTGN Stock Holding History

Franklin Resources’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-303,218
Closed -$1.38M – 2387
2022
Q3 		$1.38M Sell
303,218
-11,747
-4% -$116K ﹤0.01% 1443
2022
Q2 		$8.31M Sell
314,965
-16,386
-5% -$579K ﹤0.01% 992
2022
Q1 		$12.3M Sell
331,351
-5,916
-2% -$258K ﹤0.01% 961
2021
Q4 		$19.7M Sell
337,267
-14
-0% -$911 0.01% 893
2021
Q3 		$27.7M Buy
337,281
+5,926
+2% +$515K 0.01% 816
2021
Q2 		$31.3M Sell
331,355
-30,843
-9% -$2.29M 0.01% 765
2021
Q1 		$23.1M Buy
362,198
+154,185
+74% +$10.3M 0.01% 805
2020
Q4 		$12.1M Buy
+208,013
New +$5.31M 0.01% 922

Other funds holding VTGN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.6B AUM 18.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return